NCT01196923View on ClinicalTrials.gov

Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

June 30, 2012

Conditions
Atrial Fibrillation
Interventions
DEVICE

Endoscopically Guided Ablation

Visually Guided Ablation using EAS-AC

Trial Locations (1)

Unknown

Centro Cardiologico Monzino, Milan

Sponsors

Lead Sponsor

CardioFocus
All Listed Sponsors
lead

CardioFocus

INDUSTRY